MedTrace Logo

Epidural Fentanyl for 2nd Stage Labor Analgesia

NCT03120780 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2025-03-27

No results posted yet for this study

Summary

This study is being done to investigate if there is more effective pain relief during the latter stages of labor and delivery when epidural fentanyl 100mcg is administered compared to epidural fentanyl 20mcg.

Conditions

  • Labor Pain

Interventions

DRUG

Fentanyl 20 mcg

20 mcg fentanyl in 10 mL 0.125% bupivacaine

DRUG

Fentanyl 100 mcg

100 mcg fentanyl in 10 mL 0.125% bupivacaine

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • John Coffman, MD · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-26
Primary Completion
2024-11-13
Completion
2024-11-13
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03120780 on ClinicalTrials.gov